XML 21 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Consolidated Condensed Balance Sheets - USD ($)
$ in Millions
Sep. 28, 2024
Sep. 30, 2023
Assets    
Cash and cash equivalents $ 1,717 $ 573
Accounts receivable, net 2,406 2,476
Inventories 5,195 5,328
Other current assets 433 345
Total Current Assets 9,751 8,722
Net Property, Plant and Equipment 9,442 9,634
Goodwill, net 9,819 9,878
Intangible Assets, net 5,875 6,098
Other Assets 2,213 1,919
Total Assets 37,100 36,251
Liabilities and Shareholders' Equity    
Current debt 74 1,895
Accounts payable 2,402 2,594
Other current liabilities 2,311 2,010
Total Current Liabilities 4,787 6,499
Total long-term debt 9,713 7,611
Deferred Income Taxes 2,285 2,308
Other Liabilities 1,801 1,578
Shareholders' Equity:    
Capital in excess of par value 4,597 4,560
Retained earnings 18,873 18,760
Accumulated other comprehensive gain (loss) (184) (260)
Treasury stock, at cost – 88 million shares at October 1, 2022 and 83 million shares at October 2, 2021 (4,941) (4,972)
Total Tyson Shareholders’ Equity 18,390 18,133
Noncontrolling Interests 124 122
Total Shareholders’ Equity 18,514 18,255
Total Liabilities and Shareholders’ Equity 37,100 36,251
Class A [Member]    
Shareholders' Equity:    
Common stock ($0.10 par value): 38 38
Class B [Member]    
Shareholders' Equity:    
Common stock ($0.10 par value): $ 7 $ 7